Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination.

MLA

Busse, Antonia, et al. “Mutation or Loss of Wilms’ Tumor Gene 1 (WT1) Are Not Major Reasons for Immune Escape in Patients with AML Receiving WT1 Peptide Vaccination.” Journal of Translational Medicine, vol. 8, Jan. 2010, p. 5. EBSCOhost, https://doi.org/10.1186/1479-5876-8-5.

APA

Busse, A., Letsch, A., Scheibenbogen, C., Nonnenmacher, A., Ochsenreither, S., Thiel, E., & Keilholz, U. (2010). Mutation or loss of Wilms’ tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination. Journal of Translational Medicine, 8, 5. https://doi.org/10.1186/1479-5876-8-5

Chicago

Busse, Antonia, Anne Letsch, Carmen Scheibenbogen, Anika Nonnenmacher, Sebastian Ochsenreither, Eckhard Thiel, and Ulrich Keilholz. 2010. “Mutation or Loss of Wilms’ Tumor Gene 1 (WT1) Are Not Major Reasons for Immune Escape in Patients with AML Receiving WT1 Peptide Vaccination.” Journal of Translational Medicine 8 (January): 5. doi:10.1186/1479-5876-8-5.